Svennilson Peter
Latest statistics and disclosures from Svennilson Peter's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Ngm Biopharmaceuticals, RVMD, NRIX, RAPT, Constellation Pharmceticls I, and represent 90.08% of Svennilson Peter's stock portfolio.
- Added to shares of these 2 stocks: NRIX (+$236M), Ngm Biopharmaceuticals.
- Started 1 new stock position in NRIX.
- Reduced shares in these 3 stocks: RCUS (-$44M), RAPT (-$37M), GRTS.
- Sold out of its position in RCUS.
- Svennilson Peter was a net buyer of stock by $158M.
- Svennilson Peter has $1.2B in assets under management (AUM), dropping by 2.49%.
- Central Index Key (CIK): 0001606074
Tip: Access up to 7 years of quarterly data
Positions held by Svennilson Peter consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Svennilson Peter
Svennilson Peter holds 7 positions in its portfolio as reported in the September 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Ngm Biopharmaceuticals | 23.4 | $287M | 18M | 15.91 |
|
|
Revolution Medicines (RVMD) | 22.7 | $278M | 8.0M | 34.80 |
|
|
Nurix Therapeutics (NRIX) | 19.2 | $236M | NEW | 6.8M | 34.91 |
|
Rapt Therapeutics (RAPT) | 14.8 | $181M | -16% | 5.6M | 32.20 |
|
Constellation Pharmceticls I | 10.0 | $123M | 6.1M | 20.26 |
|
|
Oric Pharmaceuticals (ORIC) | 9.7 | $119M | 4.8M | 25.01 |
|
|
Gritstone Oncology Ord (GRTS) | 0.2 | $2.3M | -48% | 870k | 2.65 |
|
Past Filings by Svennilson Peter
SEC 13F filings are viewable for Svennilson Peter going back to 2018
- Svennilson Peter 2020 Q3 filed Nov. 4, 2020
- Svennilson Peter 2020 Q2 filed Aug. 12, 2020
- Svennilson Peter 2020 Q1 filed May 7, 2020
- Svennilson Peter 2019 Q4 filed Feb. 12, 2020
- Svennilson Peter 2019 Q3 filed Nov. 14, 2019
- Svennilson Peter 2019 Q2 filed Aug. 14, 2019
- Svennilson Peter 2019 Q1 filed May 8, 2019
- Svennilson Peter 2018 Q4 filed Feb. 13, 2019